These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 27094369)
1. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy. Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369 [TBL] [Abstract][Full Text] [Related]
2. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy. Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607 [TBL] [Abstract][Full Text] [Related]
3. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. Meng C; Su H; Shu M; Shen F; Lu Y; Wu S; Su Z; Yu M; Yang D Cell Death Dis; 2024 Sep; 15(9):683. PubMed ID: 39294131 [TBL] [Abstract][Full Text] [Related]
4. PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy. Wang L; Li Z; Tan Y; Li Q; Yang H; Wang P; Lu J; Liu P Mol Cell Endocrinol; 2018 Oct; 474():137-150. PubMed ID: 29501586 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy. Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328 [TBL] [Abstract][Full Text] [Related]
6. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway. Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023 [TBL] [Abstract][Full Text] [Related]
7. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy. Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy. Frias MA; Rebsamen MC; Gerber-Wicht C; Lang U Cardiovasc Res; 2007 Jan; 73(1):57-65. PubMed ID: 17067562 [TBL] [Abstract][Full Text] [Related]
10. PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3. Wang M; Li J; Ding Y; Cai S; Li Z; Liu P Eur J Pharmacol; 2021 Sep; 906():174283. PubMed ID: 34174269 [TBL] [Abstract][Full Text] [Related]
11. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte. Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056 [TBL] [Abstract][Full Text] [Related]
12. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway. Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway. Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953 [TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro. Autelitano DJ; Ridings R; Tang F Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465 [TBL] [Abstract][Full Text] [Related]
16. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. Takahashi N; Saito Y; Kuwahara K; Harada M; Tanimoto K; Nakagawa Y; Kawakami R; Nakanishi M; Yasuno S; Usami S; Yoshimura A; Nakao K J Mol Cell Cardiol; 2005 Jan; 38(1):185-92. PubMed ID: 15623435 [TBL] [Abstract][Full Text] [Related]
17. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503 [TBL] [Abstract][Full Text] [Related]
18. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300. Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368 [TBL] [Abstract][Full Text] [Related]
19. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin. Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1. Li YJ; Cui W; Tian ZJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Xie RQ; Yang XH; Wu YZ; Chen L; An W Chin Med J (Engl); 2004 Aug; 117(8):1135-42. PubMed ID: 15361284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]